216 related articles for article (PubMed ID: 37143440)
41. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
[TBL] [Abstract][Full Text] [Related]
42.
Siozopoulou V; Marcq E; De Winne K; Norga K; Schmitz G; Duwel V; Delvenne P; Smits E; Pauwels P
Pathol Oncol Res; 2022; 28():1610423. PubMed ID: 35645621
[TBL] [Abstract][Full Text] [Related]
43. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities.
Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G
Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients.
Silvertown JD; Lisle C; Semenuk L; Knapp C; Jaynes J; Berg D; Kaul N; Lachapelle J; Richardson L; Speevak M; Sarras H; Berman DM; Carter R; Feilotter H; Feltis T
Mol Diagn Ther; 2023 Jan; 27(1):87-103. PubMed ID: 36194351
[TBL] [Abstract][Full Text] [Related]
45. NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
Chou A; Fraser T; Ahadi M; Fuchs T; Sioson L; Clarkson A; Sheen A; Singh N; Corless CL; Gill AJ
Mod Pathol; 2020 May; 33(5):924-932. PubMed ID: 31792356
[TBL] [Abstract][Full Text] [Related]
46. Detection of
Koopman B; Kuijpers CCHJ; Groen HJM; Timens W; Schuuring E; Willems SM; van Kempen LC
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328221
[TBL] [Abstract][Full Text] [Related]
47. CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing.
Stockley TL; Lo B; Box A; Corredor AG; DeCoteau J; Desmeules P; Feilotter H; Grafodatskaya D; Greer W; Hawkins C; Huang WY; Izevbaye I; Lépine G; Martins Filho SN; Papadakis AI; Park PC; Riviere JB; Sheffield BS; Spatz A; Spriggs E; Tran-Thanh D; Yip S; Zhang T; Torlakovic E; Tsao MS
J Mol Diagn; 2023 Mar; 25(3):168-174. PubMed ID: 36586421
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma].
Jiang YY; Chen H; Xu BL; Wang S
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162
[No Abstract] [Full Text] [Related]
49. Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase.
Eyerer FIR; Bradshaw G; Vasalos P; Laser JS; Chang CC; Kim AS; Olson DR; Paler RJ; Rosenbaum JN; Walk EE; Willis JE; Yao J; Yohe SL
Arch Pathol Lab Med; 2023 Aug; 147(8):872-884. PubMed ID: 36508682
[TBL] [Abstract][Full Text] [Related]
50. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z
Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594
[TBL] [Abstract][Full Text] [Related]
51. A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract][Full Text] [Related]
52. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
Ukkola I; Nummela P; Kero M; Tammio H; Tuominen J; Kairisto V; Kallajoki M; Haglund C; Peltomäki P; Kytölä S; Ristimäki A
Virchows Arch; 2022 Apr; 480(4):807-817. PubMed ID: 35237889
[TBL] [Abstract][Full Text] [Related]
53. China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.
Qi C; Zhou T; Bai Y; Chen H; Yuan J; Zhao F; Liu C; Ma M; Bei T; Chen S; Zhao X; Chen C; Shen L
Int J Cancer; 2023 Dec; 153(11):1916-1927. PubMed ID: 36946696
[TBL] [Abstract][Full Text] [Related]
54. NTRK fusions and Trk proteins: what are they and how to test for them.
Weiss LM; Funari VA
Hum Pathol; 2021 Jun; 112():59-69. PubMed ID: 33794242
[TBL] [Abstract][Full Text] [Related]
55. NTRK gene fusions are detected in both secretory and non-secretory breast cancers.
Maund SL; Sokol ES; Ang Houle A; Ross JS; Wilson TR
Pathol Int; 2022 Mar; 72(3):187-192. PubMed ID: 35102630
[TBL] [Abstract][Full Text] [Related]
56. NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
Kirchner M; Glade J; Lehmann U; Merkelbach-Bruse S; Hummel M; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Ploeger C; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A; Pfarr N
Genes Chromosomes Cancer; 2020 Aug; 59(8):445-453. PubMed ID: 32319699
[TBL] [Abstract][Full Text] [Related]
57. NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China.
Yin L; Shi C; He X; Qiu Y; Chen H; Chen M; Zhang Z; Chen Y; Zhou Y; Zhang H
Pathology; 2023 Apr; 55(3):362-374. PubMed ID: 36641377
[TBL] [Abstract][Full Text] [Related]
58. Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
de Oliveira Cavagna R; de Andrade ES; Tadin Reis M; de Paula FE; Noriz Berardinelli G; Bonatelli M; Ramos Teixeira G; Garbe Zaniolo B; Mourão Dias J; da Silva FAF; Baston Silva CE; Xavier Reis M; Lopes Maia E; de Alencar TS; Jacinto AA; da Nóbrega Oliveira REN; Molina-Vila MA; Ferro Leal L; Reis RM
Sci Rep; 2023 Dec; 13(1):21168. PubMed ID: 38036758
[TBL] [Abstract][Full Text] [Related]
59. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
60. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
